Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s stock price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$13.36 and traded as low as C$10.62. Cipher Pharmaceuticals shares last traded at C$10.92, with a volume of 43,185 shares trading hands.
Analyst Ratings Changes
Separately, Stifel Nicolaus dropped their target price on Cipher Pharmaceuticals from C$19.00 to C$17.00 in a research report on Monday, November 11th.
Cipher Pharmaceuticals Stock Down 3.3 %
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.
Recommended Stories
- Five stocks we like better than Cipher Pharmaceuticals
- Trading Halts Explained
- How to Protect Your Portfolio When Inflation Is Rising
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to Invest in Insurance Companies: A GuideĀ
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.